fluconazole has been researched along with Essential Polyarteritis in 1 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Excerpt | Relevance | Reference |
---|---|---|
" The dosage was increased (800 mg/day) following laboratory diagnosis of C." | 1.40 | Cryptococcus neoformans meningoencephalitis in a patient with polyarteritis nodosa. ( Buchta, V; Drahošová, M; Kutová, R; Mottl, R; Plíšek, S; Prášil, P; Vejsová, M, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buchta, V | 1 |
Prášil, P | 1 |
Vejsová, M | 1 |
Mottl, R | 1 |
Kutová, R | 1 |
Drahošová, M | 1 |
Plíšek, S | 1 |
1 other study available for fluconazole and Essential Polyarteritis
Article | Year |
---|---|
Cryptococcus neoformans meningoencephalitis in a patient with polyarteritis nodosa.
Topics: Antifungal Agents; Cryptococcus neoformans; Fatal Outcome; Fluconazole; Humans; Male; Meningoencepha | 2014 |